ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Triethylamine → (1S,4R)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-8-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-ylmethyl}-2-oxa-8-aza-spiro[4.5]dec-4-yl ester

HRID 747000
印刷

反応式

HRID 747000 の反応式
C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[F:15][C:16]([F:46])([F:45])[C:17]1[CH:18]=[C:19]([C@H:27]([O:29][C@@H:30]2[C@@H:35]([C:36]3[CH:41]=[CH:40][C:39]([F:42])=[CH:38][CH:37]=3)[C@H:34]([CH:43]=O)[CH2:33][CH2:32][O:31]2)[CH3:28])[CH:20]=[C:21]([C:23]([F:26])([F:25])[F:24])[CH:22]=1.FC(F)(F)C(O)=O.[CH2:54]1[C:58]2([CH2:63][CH2:62][NH:61][CH2:60][CH2:59]2)[C@@H:57]([O:64][C:65]([C@@:67]23[C:73]([CH3:75])([CH3:74])[C@@:70]([CH3:76])([CH2:71][CH2:72]2)[C:69](=[O:77])[O:68]3)=[O:66])[CH2:56][O:55]1.C(N(CC)CC)C>ClCCl>[F:46][C:16]([F:15])([F:45])[C:17]1[CH:18]=[C:19]([C@H:27]([O:29][C@@H:30]2[C@@H:35]([C:36]3[CH:37]=[CH:38][C:39]([F:42])=[CH:40][CH:41]=3)[C@H:34]([CH2:43][N:61]3[CH2:62][CH2:63][C:58]4([CH2:54][O:55][CH2:56][C@@H:57]4[O:64][C:65]([C@@:67]45[C:73]([CH3:74])([CH3:75])[C@@:70]([CH3:76])([CH2:71][CH2:72]4)[C:69](=[O:77])[O:68]5)=[O:66])[CH2:59][CH2:60]3)[CH2:33][CH2:32][O:31]2)[CH3:28])[CH:20]=[C:21]([C:23]([F:24])([F:25])[F:26])[CH:22]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 8471TriethylamineHCID 5049666Sodium triacetoxyborohydrideHCID 86601740(2R,3R,4R)-2-[(1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-carbaldehydeHCID 86606912(1S,4R)-4,7,7-trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-2-oxa-8-aza-spiro[4.5]dec-4-yl ester trifluoroacetate

生成物 1

HCID 86606911
(1S,4R)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-8-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-ylmethyl}-2-oxa-8-aza-spiro[4.5]dec-4-yl ester
収率 44.2%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

Solid sodium triacetoxyborohydride (107 mg, 0.504 mmol) was added to a stirred mixture of 2-[1-{(2R,3R,4R)-2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-tetrahydropyran-4-carbaldehyde (Description 11; 121 mg, 0.36 mmol), (1S,4R)-4,7,7-trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (4R)-2-oxa-8-aza-spiro[4.5]dec-4-yl ester trifluoroacetate (Description 10; 130 mg), triethylamine (0.1 ml, 0.72 mmol) and dichloromethane (3 ml) at room temperature. The mixture was stirred for 45 minutes, quenched with saturated aqueous NaHCO3 and extracted into dichloromethane. The organic extract was dried (Na2SO4) and concentrated. The residue was purified by preparative TLC (dichloromethane:methanol) to give the title compound (100 mg). The HCl salt was prepared and recrystallised from ethyl acetate:methanol.

後処理

  1. customquenched with saturated aqueous NaHCO3
  2. extractionextracted into dichloromethane
  3. extractionThe organic extract
  4. dry with materialwas dried (Na2SO4)
  5. concentrationconcentrated
  6. customThe residue was purified by preparative TLC (dichloromethane:methanol)

出典と根拠

ORDレコード
ord-586e6d7867a8475cbee1cb0867d77a31
出典データセット
uspto-grants-2008_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07393858B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート